Subcutaneous apomorphine for parkinsonian patients with psychiatric side effects on oral treatment.
- 1 April 1991
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 54 (4) , 372-373
- https://doi.org/10.1136/jnnp.54.4.372
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- SUBCUTANEOUS APOMORPHINE FOR ON-OFF OSCILLATIONS IN PARKINSON'S DISEASEThe Lancet, 1988
- SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONSThe Lancet, 1988
- PSYCHIATRIC SIDE-EFFECTS OF HIGH-DOSE LISURIDE THERAPY IN PARKINSONISMThe Lancet, 1986
- L-Dopa Methyl Ester—A Candidate for Chronic Systemic Delivery of L-Dopa in Parkinsonʼs DiseaseClinical Neuropharmacology, 1984
- Tremor Inhibition in Parkinson Syndrome After Apomorphine Administration Under L-Dopa and Decarboxylase-Inhibitor Basic TherapyPharmacopsychiatry, 1972